At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 30, 2026 at 20:00 ET
Two Ultragenyx insiders (CFO and Chief Medical Officer) sold a combined $125K in open-market transactions over the past week, representing just 0.005% of market cap. The sales followed the company's earnings release and are negligible relative to company size, indicating routine portfolio management rather than a negative signal.
- CFO Howard Horn sold 4,683 shares at ~$24.90 for $117K on May 1.
- Chief Medical Officer Eric Crombez sold 344 shares at $24.96 for $9K on May 5.
- Total insider sales of $125K represent 0.005% of RARE's $2.5B market cap.
- Sales occurred within one day of the company's May 5 earnings release (8-K Item 2.02).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access